Midtrimester preeclamptic toxemia in triploid pregnancies

Area of Science:

• Reproductive Medicine
• Maternal-Fetal Medicine
• Genetics

Background:

• Triploid pregnancies, a chromosomal abnormality, are rare and often associated with adverse outcomes.
• Severe preeclamptic toxemia (EPH gestosis) poses significant risks to maternal and fetal health.

Purpose of the Study:

• To review literature on advanced triploid pregnancies.
• To investigate the association between triploidy, placental abnormalities, and preeclamptic toxemia.

Main Methods:

• Literature review of 19 reported cases of advanced triploid pregnancies.
• Analysis of clinical data, including gestational week of onset, placental characteristics, and maternal outcomes.

Main Results:

• In 8 of 14 pregnancies with available data, severe preeclamptic toxemia developed between 16-24 weeks gestation.
• Toxemic cases exhibited large placentas with molar degeneration and high placental coefficients (mean 0.83).

Conclusions:

• Advanced triploid pregnancy is a model for studying hyperplacentosis-induced preeclamptic toxemia.
• Hyperplacentosis in these cases is an expression of trophoblastic hyperactivity, linked to preeclampsia development.